Rchr
J-GLOBAL ID：201101029871789368   Update date: May. 11, 2024

Okudaira Shinichi

オクダイラ シンイチ | Okudaira Shinichi
Affiliation and department：
Pharmaceuticals and Medical Devices Agency Office of International Programs

About Pharmaceuticals and Medical Devices Agency Office of International Programs


Homepage URL  (2)： https://www.pmda.go.jp ,  https://www.pmda.go.jp/english/index.html
Research field  (1)： Pharmaceuticals - chemistry and drug development
Research theme for competitive and other funds  (3)：
  • 2013 - 2014 腎線維症におけるATX/LPA経路の活性化機構の解明
  • 2011 - 2012 Roles of Lysophosphatidic Acid in Various Fibrotic Diseases
  • 2006 - 2008 ミエリンにおける生理活性脂質リゾホスファチジン酸の機能解析
Papers (31)：
  • Yoshiaki Maruyama, Shinichi Noda, Shinichi Okudaira, Akira Sakurai, Narumi Okura, Futaba Honda. Regulatory Aspects of Cell and Gene Therapy Products: The Japanese Perspective. Advances in experimental medicine and biology. 2023. 1430. 155-179
  • Shinichi Okudaira. [Points to Consider for Continuous Manufacturing of Biotechnological Drug Products]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2022. 142. 7. 745-748
  • Mitsuyasu Kawaguchi, Takayoshi Okabe, Shinichi Okudaira, Kotaro Hama, Kuniyuki Kano, Hiroshi Nishimasu, Hidehiko Nakagawa, Ryuichiro Ishitani, Hirotatsu Kojima, Osamu Nureki, et al. Identification of Potent In Vivo Autotaxin Inhibitors that Bind to Both Hydrophobic Pockets and Channels in the Catalytic Domain. Journal of medicinal chemistry. 2020. 63. 6. 3188-3204
  • Kazuki Kato, Hisako Ikeda, Shin Miyakawa, Satoshi Futakawa, Yosuke Nonaka, Masatoshi Fujiwara, Shinichi Okudaira, Kuniyuki Kano, Junken Aoki, Junko Morita, et al. Structural basis for specific inhibition of Autotaxin by a DNA aptamer. Nature structural & molecular biology. 2016. 23. 5. 395-401
  • Yukiko Tando, Chiharu Ota, Mitsuhiro Yamada, Satoshi Kamata, Mutsuo Yamaya, Kuniyuki Kano, Shinichi Okudaira, Junken Aoki, Hiroshi Kubo. The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model. Transplantation direct. 2015. 1. 9. e35
ｍore...
MISC (64)：
  • 西川 淳史, 野田 慎一, 奥平 真一, 篠原 加代, 中村 美紀, 丸山 良亮, 本田 二葉. 【細胞遺伝子治療(ex vivo)の現状と展望-CAR-T細胞療法を中心に-】規制の視点から見たCAR-T療法. 医薬品医療機器レギュラトリーサイエンス. 2023. 54. 2. 121-128
  • Okudaira Shinichi. Points to Consider for Continuous Manufacturing of Biotechnological Drug Products. YAKUGAKU ZASSHI. 2022. 142. 7. 745-748
  • OKUDAIRA Shinichi, ISHII-WATABE Akiko. Updates in Continuous Manufacturing of Biotechnological Products. Pharmaceutical and Medical Device Regulatory Science. 2022. 53. 3. 192-197
  • 奥平 真一. 抗悪性腫瘍薬のバイオ後続品の臨床試験のエンドポイント : プライマリー&セカンダリーエンドポイントの評価と意義-Endpoints in clinical trials for developing biosimilars of oncology pharmaceuticals : Evaluation and significance of primary and secondary endpoints. 腫瘍内科 = Clinical oncology / 腫瘍内科編集委員会 編. 2021. 27. 5. 579-584
  • 奥平 真一. バイオ創薬の基盤強化に向けた製造・品質管理の技術革新と国際貢献 バイオ医薬品の連続生産に関するPoints to Considerについて. 日本薬学会年会要旨集. 2021. 141年会. S36-3
ｍore...
Books (2)：
  • PHARM TECH JAPAN 2024年4月増刊号 医薬品品質トピックス 2023-2024
    じほう 2024
  • 有効性・安全性確保のためのバイオ医薬品の品質管理戦略 : クオリティ・バイ・デザインを取り入れた製造・品質管理
    じほう 2020 ISBN:9784840752329
Education (2)：
  • 2004 - 2009 The University of Tokyo Graduate School of Pharmaceutical Sciences
  • - 2004 The University of Tokyo Faculty of Pharmaceutical Sciences Department of Pharmacy
Professional career (1)：
  • Ph. D. (Pharmaceutcal Sciences) (The University of Tokyo)
Work history (4)：
  • 2013 - 現在 Pharmaceuticals and Medical Devices Agency
  • 2011 - 2013 Tohoku University Graduate School of Pharmaceutical Sciences, Division of Bio-Pharmaceutical Science, Molecular Pharmaceutics,Laboratory of Molecular and Cellular Biochemistry Assistant Professor
  • 2009 - 2011 東北大学 大学院薬学研究科 生命薬科学専攻 生命解析学講座 分子細胞生化学分野 研究員
  • 2006 - 2009 日本学術振興会 特別研究員DC1
Association Membership(s) (1)：
日本薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM